Hotels and pipelines drive Loews profits higher as insurance underwriting softens

Impact · against what's priced in

Loews Corp's results show a concerning trend in its core insurance underwriting, which is being masked by strength in hospitality and investment income. Genflow Biosciences receives a positive catalyst from strengthened US patent protections for its therapeutic pipeline.

GENF+0.30

No priced-in read yet

In context

The company has achieved accelerated US patent examination for its SIRT6 gene variant, which strengthens protection across its entire therapeutic pipeline.

Read from the article alone

• earnings
• GENF
• L
• buybacks
• conglomerate
• hotels
• insurance
• natural gas
• net income
• pipelines

Search tags